Galectin-3 predicts response and outcomes after cardiac resynchronization therapy

BACKGROUND: Cardiac resynchronization therapy (CRT) reduces symptoms, morbidity and mortality in chronic heart failure patients with wide QRS complexes. However, approximately one third of CRT patients are non-responders. Myocardial fibrosis is known to be associated with absence of response. We sou...

Descripción completa

Detalles Bibliográficos
Autores principales: Andre, Clémentine, Piver, Eric, Perault, Romain, Bisson, Arnaud, Pucheux, Julien, Vermes, Emmanuelle, Pierre, Bertrand, Fauchier, Laurent, Babuty, Dominique, Clementy, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215623/
https://www.ncbi.nlm.nih.gov/pubmed/30390680
http://dx.doi.org/10.1186/s12967-018-1675-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215623/
https://www.ncbi.nlm.nih.gov/pubmed/30390680
http://dx.doi.org/10.1186/s12967-018-1675-4

Ejemplares similares